AbbVie (ABBV) lowers 2025 adj. EPS guidance to USD 9.90-9.94 including milestones expense; Q4 25 view adj. EPS 2.61-2.65
Importance
Level 1
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#ABBVIE INC#ABBV.US#FOREX#EQUITIES#METALS#ASIAN SESSION#US SESSION#BIOTECHNOLOGY#METALS & MINING#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ABBVIE INC#ABBV#DXY#US EQUITIES